Pfizer Problem - Search News

Pfizer Lyme Disease Vaccine Shows 70% Efficacy

Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle

An experimental vaccine from Pfizer and Valneva reduced the risk of developing Lyme disease by more than 70 percent, according to newly released data.

Continue reading

· 1d · on MSN

Pfizer’s Lyme vaccine shows strong efficacy but misses mark in study

Pfizer Lyme vaccine shows 70% efficacy, misses trial goal

Pfizer says Lyme disease vaccine is holding promise

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease.

Continue reading

Mixed results for Lyme disease vaccine hit Valneva shares

Pfizer to seek FDA approval for Lyme vaccine as CT report shows ticks are more abundant than ever